Distal Renal Tubular Acidosis clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 6 months to 65 years
This is a phase 3, prospective, multicenter, randomized, double-blinded, placebo-controlled, study product withdrawal study comparing the efficacy of ADV7103 versus placebo in preventing the development of metabolic acidosis defined by serum bicarbonate level in pediatric (6 months to < 18 years of age) and adult (18 to 65 years of age) subjects with primary dRTA.
San Francisco, California and other locations